AARTIPHARM — Aarti Pharmalabs Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹45.20bn
- IN₹46.18bn
- IN₹19.45bn
- 47
- 25
- 71
- 44
2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | Interim Report | Interim Report | ARS |
Standards: | — | — | IAS |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 2.5 | 1,603 | 990 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0 | 3,882 | 4,524 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 2.5 | 10,281 | 11,558 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 0 | 9,453 | 9,861 |
Net Goodwill | |||
Net Intangible Assets | |||
Long Term Investments | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 2.5 | 20,399 | 22,309 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 0.219 | 5,807 | 5,916 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Total Other Liabilities | |||
Total Funded Status | |||
Total Liabilities | 0.219 | 6,534 | 6,724 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 2.28 | 13,865 | 15,585 |
Total Liabilities & Shareholders' Equity | 2.5 | 20,399 | 22,309 |
Total Common Shares Outstanding |